Page last updated: 2024-09-03

odapipam and dihydroxyphenylalanine

odapipam has been researched along with dihydroxyphenylalanine in 1 studies

*Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. [MeSH]

*Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. [MeSH]

Compound Research Comparison

Studies
(odapipam)
Trials
(odapipam)
Recent Studies (post-2010)
(odapipam)
Studies
(dihydroxyphenylalanine)
Trials
(dihydroxyphenylalanine)
Recent Studies (post-2010) (dihydroxyphenylalanine)
19438,823322833

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aalto, S; Eskola, O; Forssell, H; Hagelberg, N; Jääskeläinen, SK; Någren, K; Rinne, JO; Scheinin, H; Taiminen, T1

Other Studies

1 other study(ies) available for odapipam and dihydroxyphenylalanine

ArticleYear
Altered dopamine D2 receptor binding in atypical facial pain.
    Pain, 2003, Volume: 106, Issue:1-2

    Topics: Aged; Benzazepines; Benzofurans; Carbon Radioisotopes; Dihydroxyphenylalanine; Dopamine Antagonists; Facial Pain; Humans; Middle Aged; Putamen; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed

2003